These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
939 related articles for article (PubMed ID: 16938327)
1. A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice. Li J; Faber M; Papaneri A; Faber ML; McGettigan JP; Schnell MJ; Dietzschold B Virology; 2006 Dec 5-20; 356(1-2):147-54. PubMed ID: 16938327 [TBL] [Abstract][Full Text] [Related]
2. Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine. Henderson H; Jackson F; Bean K; Panasuk B; Niezgoda M; Slate D; Li J; Dietzschold B; Mattis J; Rupprecht CE Vaccine; 2009 Nov; 27(51):7194-7. PubMed ID: 19925952 [TBL] [Abstract][Full Text] [Related]
3. [Construction and immunogenicity of recombinant Canine adenovirus type 2 with the external part of glycoprotein of rabies virus]. Wang YZ; Zhang SF; Hu RL; Wang X; Xiao YQ Wei Sheng Wu Xue Bao; 2005 Apr; 45(2):213-7. PubMed ID: 15989263 [TBL] [Abstract][Full Text] [Related]
4. Canine adenovirus based rabies vaccines. Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509 [TBL] [Abstract][Full Text] [Related]
5. Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper. Wang X; Feng N; Ge J; Shuai L; Peng L; Gao Y; Yang S; Xia X; Bu Z Vaccine; 2012 Jul; 30(34):5067-72. PubMed ID: 22698451 [TBL] [Abstract][Full Text] [Related]
6. Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies. Weyer J; Rupprecht CE; Mans J; Viljoen GJ; Nel LH Vaccine; 2007 May; 25(21):4213-22. PubMed ID: 17434244 [TBL] [Abstract][Full Text] [Related]
7. [Construction and identification of recombinant canine adenovirus type 2 expressing exogenous rabies glycoprotein (Rgp)]. Zhao ZP; Xia XZ; Hu RL; Xie ZJ; Yan F; Huang G; Yang ST Wei Sheng Wu Xue Bao; 2007 Apr; 47(2):335-9. PubMed ID: 17552245 [TBL] [Abstract][Full Text] [Related]
8. DNA vaccine for rabies: relevance of the trans-membrane domain of the glycoprotein in generating an antibody response. Rath A; Choudhury S; Batra D; Kapre SV; Rupprecht CE; Gupta SK Virus Res; 2005 Nov; 113(2):143-52. PubMed ID: 15978691 [TBL] [Abstract][Full Text] [Related]
9. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines. Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013 [TBL] [Abstract][Full Text] [Related]
10. Enhancing comparative rabies DNA vaccine effectiveness through glycoprotein gene modifications. Osinubi MO; Wu X; Franka R; Niezgoda M; Nok AJ; Ogunkoya AB; Rupprecht CE Vaccine; 2009 Nov; 27(51):7214-8. PubMed ID: 19925956 [TBL] [Abstract][Full Text] [Related]
11. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection. Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325 [TBL] [Abstract][Full Text] [Related]
12. A recombinant pseudorabies virus expressing rabies virus glycoprotein: safety and immunogenicity in dogs. Yuan Z; Zhang S; Liu Y; Zhang F; Fooks AR; Li Q; Hu R Vaccine; 2008 Mar; 26(10):1314-21. PubMed ID: 18262313 [TBL] [Abstract][Full Text] [Related]
13. Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene. Cenna J; Tan GS; Papaneri AB; Dietzschold B; Schnell MJ; McGettigan JP Vaccine; 2008 Nov; 26(50):6405-14. PubMed ID: 18804506 [TBL] [Abstract][Full Text] [Related]
14. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species. Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811 [TBL] [Abstract][Full Text] [Related]
15. Prevention of rabies virus infection in dogs by a recombinant canine adenovirus type-2 encoding the rabies virus glycoprotein. Hu R; Zhang S; Fooks AR; Yuan H; Liu Y; Li H; Tu C; Xia X; Xiao Y Microbes Infect; 2006 Apr; 8(4):1090-7. PubMed ID: 16524754 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine. Liu Y; Zhang S; Ma G; Zhang F; Hu R Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839 [TBL] [Abstract][Full Text] [Related]
17. Development of rabies DNA vaccine using a recombinant plasmid. Rai N; Kaushik P; Rai A Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518 [TBL] [Abstract][Full Text] [Related]
18. Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein. Loza-Rubio E; Rojas-Anaya E; López J; Olivera-Flores MT; Gómez-Lim M; Tapia-Pérez G Vaccine; 2012 Aug; 30(37):5551-6. PubMed ID: 22749836 [TBL] [Abstract][Full Text] [Related]
19. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies. Zhang S; Liu Y; Fooks AR; Zhang F; Hu R Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277 [TBL] [Abstract][Full Text] [Related]
20. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies. Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]